Developer docs
API playgroundTry for free, no card

Search company profiles

Wellmicro

Full company profile

uuid000lv6r

Namestring
Wellmicro
Legal namestring
Wellmicro S.r.l.
Websiteurl
wellmicro.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Wellmicro S.r.l. is an Italian biotechnology company founded in 2015 and headquartered in Bologna (operational) and Bussolengo (legal). It operates a specialized laboratory focused exclusively on human microbiota analysis, offering shotgun metagenomic sequencing-based gut and vaginal microbiota tests on the Illumina NovaSeq 6000Dx platform, followed by advanced bioinformatics interpretation that profiles bacteria, fungi (miceti), DNA viruses, and parasites (protozoa and metazoa). Wellmicro holds what it describes as the first Italian patent on a method for analyzing intestinal microbiota data, and positions itself against standardized, one-size-fits-all healthcare by offering personalized microbiome profiling.

The company's commercial portfolio comprises three SKUs sold individually or as a combo: the Wellmicro® Gut Test Plus, the Wellmicro® Vaginal Test, and a combined Gut + Vaginal Combo package. It monetizes through one-time consumer test-kit sales and through professional consulting services for healthcare professionals, primarily physicians (gastroenterologists, gynecologists) and pharmacies.

Distribution is omnichannel within Italy: direct-to-consumer via the e-commerce platform at app.wellmicro.com, through a partnered physician network, and through a partnered pharmacy network, with dedicated "Find a Doctor" and "Find a Pharmacy" locators on the corporate website. Marketing is conducted via the Wellmicro® Academy (scientific publications and educational content for clinicians), corporate social media (LinkedIn, Facebook, Instagram, YouTube), and a Medical News section on the website. The company has also entered co-marketing partnerships with Italian wellness brands Named® and Specchiasol® to advance its personalized-medicine positioning. The team is small (1–10 employees) and the company is privately held with no disclosed institutional funding.

Short descriptiontext

Wellmicro is an Italian biotech laboratory founded in 2015 that sells shotgun metagenomic gut and vaginal microbiota tests directly to consumers, physicians, and pharmacies in Italy, using patented bioinformatics on the Illumina NovaSeq 6000Dx platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBologna, Italy
HQ citystring
Bologna
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiota testing services, metagenomic sequencing analysis, gut health diagnostics, vaginal microbiome testing, bioinformatics laboratory services
Industry2 codes
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Microbiome Diagnostic Testing Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Microbiota Testing Products
TypeOne Time License
Description

Sale of gut and vaginal microbiota test kits to consumers, healthcare professionals, and pharmacies

wellmicro.com
2Professional Consulting Services
TypeProfessional Services
Description

Partnership and consulting services for healthcare professionals

wellmicro.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Wellmicro® Gut Test Plus - Metagenomic Revolution
Description

Intestinal microbiota test analyzing bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa) through shotgun sequencing on NovaSeq 6000Dx - Illumina® platform.

wellmicro.com
+2 more records
Core offering1 text field

Wellmicro operates a specialized diagnostic laboratory that analyzes human microbiota composition through shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform. The company offers gut and vaginal microbiota test kits that profile bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa), producing reports that compare patient samples against healthy controls and are used to support personalized dietary and therapeutic decisions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Wellmicro is a microbiota-based company offering specialized laboratory tests for analyzing human microbiota composition. The product portfolio consists of two core diagnostic tests—Wellmicro® Gut Test Plus and Wellmicro® Vaginal Test—both using shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform with advanced bioinformatics analysis. These tests are available individually or as a combo package, enabling comprehensive 360-degree microbiota analysis for both intestinal and vaginal samples. The company positions itself as the first in Italy with a patented method for analyzing intestinal microbiota data.

Product and service1 record
1Wellmicro® Gut Test Plus - Metagenomic Revolution
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Named® partnered with Wellmicro® for wellness initiatives, sharing the vision of personalized and precise medicine over standardized approaches.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Specchiasol® partnered with Wellmicro® for wellness initiatives, aligned with the vision of personalized healthcare.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-headquartered DTC microbiome testing company offering gut microbiome and DNA testing directly to consumers with personalized health recommendations. Highly comparable to Wellmicro as a DTC-first, sequencing-based microbiota testing brand with a similar consumer+professional proposition.

TypeDirect peer
Description

US-based DTC microbiome testing company using metatranscriptomic sequencing to profile gut and oral microbiota and sell personalized nutrition recommendations. Comparable to Wellmicro on technology (high-resolution sequencing), product (microbiome test kits), and go-to-market (DTC + wellness partnerships).

TypeDirect peer
Description

Microbiome-based personalized nutrition company (Israel/US) that uses gut microbiome profiling to recommend individualized food and glucose responses. Comparable to Wellmicro in applying shotgun microbiome data to clinical/personalized nutrition decisions, though with a B2B payer focus.

TypeBroad incumbent
Description

UK/US personalized nutrition platform combining gut microbiome testing with continuous glucose monitoring and blood fat responses. Comparable to Wellmicro as a consumer-facing gut microbiome testing brand, but operates at a much larger scale with a broader integrated wellness platform.

TypeRegional player
Description

Australia-based microbiome profiling and analysis company offering gut microbiome testing to consumers and B2B microbiome analysis services. Comparable to Wellmicro in shotgun metagenomic sequencing methodology and DTC + B2B dual model, but serves the APAC market rather than Europe.

TypeDirect peer
Description

US-based microbiome analytics and sequencing services company offering CLIA-certified gut microbiome testing and bioinformatics platforms for researchers, clinicians, and consumers. Comparable to Wellmicro on shotgun sequencing technology and clinical/professional channel focus, but with a stronger B2B research emphasis.

TypeDirect peer
Description

US-based gut and vaginal microbiome testing company selling test kits directly to consumers with personalized nutrition and probiotic recommendations. Directly comparable to Wellmicro on the dual gut + vaginal testing portfolio and DTC model.

TypeDirect peer
Description

US-based personalized microbiome company offering whole-genome shotgun sequencing gut tests with custom probiotic formulations. Comparable to Wellmicro on sequencing technology, DTC kit model, and personalized recommendation engine.

TypeOthers
Description

Canadian company (part of OraSure Technologies) supplying stool sample collection kits (OMNIgene·GUT) used by microbiome testing labs worldwide. Comparable to Wellmicro as a microbiome sample collection and processing enabler in the same ecosystem.

TypeOthers
Description

US-based sequencing platform manufacturer whose NovaSeq 6000Dx platform is the foundational instrument used by Wellmicro for shotgun metagenomic sequencing. Comparable as the key enabling technology vendor in the microbiome sequencing stack that Wellmicro depends on.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wellmicro

Microbiome Diagnostic Testing Serviceswellmicro.com

Wellmicro is an Italian biotech laboratory founded in 2015 that sells shotgun metagenomic gut and vaginal microbiota tests directly to consumers, physicians, and pharmacies in Italy, using patented bioinformatics on the Illumina NovaSeq 6000Dx platform.

What Wellmicro does

Wellmicro S.r.l. is an Italian biotechnology company founded in 2015 and headquartered in Bologna (operational) and Bussolengo (legal). It operates a specialized laboratory focused exclusively on human microbiota analysis, offering shotgun metagenomic sequencing-based gut and vaginal microbiota tests on the Illumina NovaSeq 6000Dx platform, followed by advanced bioinformatics interpretation that profiles bacteria, fungi (miceti), DNA viruses, and parasites (protozoa and metazoa). Wellmicro holds what it describes as the first Italian patent on a method for analyzing intestinal microbiota data, and positions itself against standardized, one-size-fits-all healthcare by offering personalized microbiome profiling.

The company's commercial portfolio comprises three SKUs sold individually or as a combo: the Wellmicro® Gut Test Plus, the Wellmicro® Vaginal Test, and a combined Gut + Vaginal Combo package. It monetizes through one-time consumer test-kit sales and through professional consulting services for healthcare professionals, primarily physicians (gastroenterologists, gynecologists) and pharmacies.

Distribution is omnichannel within Italy: direct-to-consumer via the e-commerce platform at app.wellmicro.com, through a partnered physician network, and through a partnered pharmacy network, with dedicated "Find a Doctor" and "Find a Pharmacy" locators on the corporate website. Marketing is conducted via the Wellmicro® Academy (scientific publications and educational content for clinicians), corporate social media (LinkedIn, Facebook, Instagram, YouTube), and a Medical News section on the website. The company has also entered co-marketing partnerships with Italian wellness brands Named® and Specchiasol® to advance its personalized-medicine positioning. The team is small (1–10 employees) and the company is privately held with no disclosed institutional funding.

Wellmicro firmographics

Firmographics
Name
Wellmicro
Legal name
Wellmicro S.r.l.
Website
https://wellmicro.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Wellmicro is an Italian biotech laboratory founded in 2015 that sells shotgun metagenomic gut and vaginal microbiota tests directly to consumers, physicians, and pharmacies in Italy, using patented bioinformatics on the Illumina NovaSeq 6000Dx platform.
Ownership category
akta.pro rank

Wellmicro industry classification

Industry
Product category
Microbiome Diagnostic Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms

Keywords

  • Microbiota testing services
  • Metagenomic sequencing analysis
  • Gut health diagnostics
  • Vaginal microbiome testing
  • Bioinformatics laboratory services

Where Wellmicro is headquartered

Location

Headquarters

HQ city
Bologna
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

Wellmicro business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Microbiota Testing Products: Sale of gut and vaginal microbiota test kits to consumers, healthcare professionals, and pharmacies
  2. Professional Consulting Services: Partnership and consulting services for healthcare professionals

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Wellmicro product offering

Product offering

Core offering

Wellmicro operates a specialized diagnostic laboratory that analyzes human microbiota composition through shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform. The company offers gut and vaginal microbiota test kits that profile bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa), producing reports that compare patient samples against healthy controls and are used to support personalized dietary and therapeutic decisions.

Product overview

Wellmicro is a microbiota-based company offering specialized laboratory tests for analyzing human microbiota composition. The product portfolio consists of two core diagnostic tests—Wellmicro® Gut Test Plus and Wellmicro® Vaginal Test—both using shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform with advanced bioinformatics analysis. These tests are available individually or as a combo package, enabling comprehensive 360-degree microbiota analysis for both intestinal and vaginal samples. The company positions itself as the first in Italy with a patented method for analyzing intestinal microbiota data.

Differentiator

Problem solved

Functional benefit

Brands

  • Wellmicro® Gut Test Plus - Metagenomic Revolution: Intestinal microbiota test analyzing bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa) through shotgun sequencing on NovaSeq 6000Dx - Illumina® platform.
  • Wellmicro® Vaginal Test - Metagenomic Revolution
  • Wellmicro® Academy

Products and services

  • Wellmicro® Gut Test Plus - Metagenomic Revolution

Companies that use Wellmicro

Customer profile

Segments3 records

Ideal customer profiles3 records

Wellmicro technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Wellmicro partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • Named®minorStrategic or Co-development PartnerNamed® partnered with Wellmicro® for wellness initiatives, sharing the vision of personalized and precise medicine over standardized approaches.
  • Specchiasol®minorStrategic or Co-development PartnerSpecchiasol® partnered with Wellmicro® for wellness initiatives, aligned with the vision of personalized healthcare.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Wellmicro competitors and assessment

Company assessment

Direct peers

  • Atlas Biomed: UK-headquartered DTC microbiome testing company offering gut microbiome and DNA testing directly to consumers with personalized health recommendations. Highly comparable to Wellmicro as a DTC-first, sequencing-based microbiota testing brand with a similar consumer+professional proposition.
  • Viome Life Sciences: US-based DTC microbiome testing company using metatranscriptomic sequencing to profile gut and oral microbiota and sell personalized nutrition recommendations. Comparable to Wellmicro on technology (high-resolution sequencing), product (microbiome test kits), and go-to-market (DTC + wellness partnerships).
  • DayTwo: Microbiome-based personalized nutrition company (Israel/US) that uses gut microbiome profiling to recommend individualized food and glucose responses. Comparable to Wellmicro in applying shotgun microbiome data to clinical/personalized nutrition decisions, though with a B2B payer focus.
  • CosmosID: US-based microbiome analytics and sequencing services company offering CLIA-certified gut microbiome testing and bioinformatics platforms for researchers, clinicians, and consumers. Comparable to Wellmicro on shotgun sequencing technology and clinical/professional channel focus, but with a stronger B2B research emphasis.
  • Biohm Health: US-based gut and vaginal microbiome testing company selling test kits directly to consumers with personalized nutrition and probiotic recommendations. Directly comparable to Wellmicro on the dual gut + vaginal testing portfolio and DTC model.
  • Sun Genomics (Thryve Inside): US-based personalized microbiome company offering whole-genome shotgun sequencing gut tests with custom probiotic formulations. Comparable to Wellmicro on sequencing technology, DTC kit model, and personalized recommendation engine.

Broad incumbents

  • ZOE: UK/US personalized nutrition platform combining gut microbiome testing with continuous glucose monitoring and blood fat responses. Comparable to Wellmicro as a consumer-facing gut microbiome testing brand, but operates at a much larger scale with a broader integrated wellness platform.

Regional players

  • Microba Life Sciences: Australia-based microbiome profiling and analysis company offering gut microbiome testing to consumers and B2B microbiome analysis services. Comparable to Wellmicro in shotgun metagenomic sequencing methodology and DTC + B2B dual model, but serves the APAC market rather than Europe.

Others

  • DNA Genotek (OMNIgene·GUT): Canadian company (part of OraSure Technologies) supplying stool sample collection kits (OMNIgene·GUT) used by microbiome testing labs worldwide. Comparable to Wellmicro as a microbiome sample collection and processing enabler in the same ecosystem.
  • Illumina: US-based sequencing platform manufacturer whose NovaSeq 6000Dx platform is the foundational instrument used by Wellmicro for shotgun metagenomic sequencing. Comparable as the key enabling technology vendor in the microbiome sequencing stack that Wellmicro depends on.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Wellmicro social profiles

Digital presence

Wellmicro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wellmicro leadership team

Management profile

Number of profiles

Profiles1 record

Wellmicro funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wellmicro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellmicro

What does Wellmicro do?

Wellmicro operates a specialized diagnostic laboratory that analyzes human microbiota composition through shotgun metagenomic sequencing on the Illumina NovaSeq 6000Dx platform. The company offers gut and vaginal microbiota test kits that profile bacteria, fungi (mycetes), DNA viruses, and parasites (protozoa and metazoa), producing reports that compare patient samples against healthy controls and are used to support personalized dietary and therapeutic decisions.

Is Wellmicro a public or private company?

Wellmicro is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Wellmicro founded?

Wellmicro was founded in 2015. It employs 11 to 50 people.

Where is Wellmicro based?

Wellmicro is headquartered in Bologna, Italy, in the Europe region.

How does Wellmicro make money?

Two revenue lines are on record. Microbiota Testing Products are the primary driver. The others are professional Consulting Services.

Who are Wellmicro's main competitors?

Direct peers on record are Atlas Biomed, Viome Life Sciences, DayTwo, CosmosID, Biohm Health and Sun Genomics (Thryve Inside). ZOE is listed as a broad incumbent. Microba Life Sciences is listed as a regional player. Others are DNA Genotek (OMNIgene·GUT) and Illumina.

Does Wellmicro have an API?

No public API is recorded for Wellmicro.

What industry is Wellmicro in?

Wellmicro's product category is Microbiome Diagnostic Testing Services. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales